Medicine catalog

Search official names, active ingredients, and BDPM codes. Cards show a readable name and form; the exact French source details are available below.

Total in catalog: 20,854 · 14 shown

Commercialized according to BDPM

BYOOVIZ 10 mg/ml, solution for injection

Active ingredients: Ranibizumab

Original BDPM details in French

Official name: BYOOVIZ 10 mg/mL, solution injectable
Active ingredients: RANIBIZUMAB
Package description: 1 flacon en verre de 0,23 mL + 1 aiguille-filtre + 1 aiguille pour injection

CIS 68654266CIP7 3027804CIP13 3400930278048

View details

Estimated price€620.90No current ANSM shortage notice is included

Commercialized according to BDPM

BYOOVIZ 10 mg/ml, solution for injection in a pre-filled syringe

Active ingredients: Ranibizumab

Original BDPM details in French

Official name: BYOOVIZ 10 mg/mL, solution injectable en seringue préremplie
Active ingredients: RANIBIZUMAB
Package description: 1 seringue préremplie de 0,165 mL

CIS 66082489CIP7 3033407CIP13 3400930334072

View details

Estimated price€620.90No current ANSM shortage notice is included

Commercialized according to BDPM

LUCENTIS 10 mg/ml, solution for injection in a pre-filled syringe

Active ingredients: Ranibizumab

Original BDPM details in French

Official name: LUCENTIS 10 mg/ml, solution injectable en seringue préremplie
Active ingredients: RANIBIZUMAB
Package description: 1 seringue(s) préremplie(s) en verre de 0,165 ml

CIS 64339586CIP7 2767119CIP13 3400927671197

View details

Estimated price€620.90No current ANSM shortage notice is included

Commercialized according to BDPM

RANIVISIO 10 mg/ml, solution for injection

Active ingredients: Ranibizumab

Original BDPM details in French

Official name: RANIVISIO 10 mg/mL, solution injectable
Active ingredients: RANIBIZUMAB
Package description: 1 flacon(s) en verre de 0,23 ml

CIS 64389258CIP7 3025867CIP13 3400930258675

View details

Estimated price€620.90No current ANSM shortage notice is included

Commercialized according to BDPM

RANIVISIO 10 mg/ml, solution for injection in a pre-filled syringe

Active ingredients: Ranibizumab

Original BDPM details in French

Official name: RANIVISIO 10 mg/mL, solution injectable en seringue préremplie
Active ingredients: RANIBIZUMAB
Package description: 1 seringue(s) préremplie(s) polyoléfine cyclique (COP) de 0,165 ml avec adaptateur

CIS 68594506CIP7 3032039CIP13 3400930320396

View details

Estimated price€620.90No current ANSM shortage notice is included

Commercialized according to BDPM

RIMMYRAH 10 mg/ml, solution for injection

Active ingredients: Ranibizumab

Original BDPM details in French

Official name: RIMMYRAH 10 mg/ml, solution injectable
Active ingredients: RANIBIZUMAB
Package description: 1 flacon(s) en verre de 0,23 ml avec aiguille(s) filtre(s)

CIS 61190863CIP7 3028396CIP13 3400930283967

View details

Estimated price€620.90No current ANSM shortage notice is included

Commercialized according to BDPM

XIMLUCI 10 mg/ml, solution for injection

Active ingredients: Ranibizumab

Original BDPM details in French

Official name: XIMLUCI 10 mg/mL, solution injectable
Active ingredients: RANIBIZUMAB
Package description: 1 flacon(s) en verre de 0,23 ml avec aiguille(s) filtre(s)

CIS 67026689CIP7 3026692CIP13 3400930266922

View details

Estimated price€620.90No current ANSM shortage notice is included

Commercialized according to BDPM

SKYRIZI 150 mg, solution for injection in a pre-filled syringe

Active ingredients: Risankizumab

Original BDPM details in French

Official name: SKYRIZI 150 mg, solution injectable en seringue préremplie
Active ingredients: RISANKIZUMAB
Package description: 1 seringue(s) préremplie(s) en verre de 1 ml

CIS 69949390CIP7 3022815CIP13 3400930228159

View details

Estimated price€4,965.70No current ANSM shortage notice is included

Commercialized according to BDPM

SKYRIZI 150 mg, solution for injection in a pre-filled pen

Active ingredients: Risankizumab

Original BDPM details in French

Official name: SKYRIZI 150 mg, solution injectable en stylo prérempli
Active ingredients: RISANKIZUMAB
Package description: 1 seringue(s) préremplie(s) en verre de 1 ml dans stylo pré-rempli

CIS 66047342CIP7 3022814CIP13 3400930228142

View details

Estimated price€4,965.70No current ANSM shortage notice is included

Commercialized according to BDPM

SKYRIZI 360 mg, solution for injection in a cartridge

Active ingredients: Risankizumab

Original BDPM details in French

Official name: SKYRIZI 360 mg, solution injectable en cartouche
Active ingredients: RISANKIZUMAB
Package description: 1 cartouche(s) copolymère de cyclooléfines (COC) de 2,4 mL avec dispositif(s) d'administration

CIS 61512595CIP7 3026258CIP13 3400930262580

View details

Estimated price€4,368.96No current ANSM shortage notice is included

Commercialized according to BDPM

SKYRIZI 600 mg, concentrate for solution for infusion

Active ingredients: Risankizumab

Original BDPM details in French

Official name: SKYRIZI 600 mg, solution à diluer pour perfusion
Active ingredients: RISANKIZUMAB
Package description: 1 flacon(s) en verre de 10 ml

CIS 64900681CIP7 5509201CIP13 3400955092018

View details

Estimated priceAsk the manager for the priceNo current ANSM shortage notice is included

Commercialized according to BDPM

SKYRIZI 75 mg, solution for injection in a pre-filled syringe

Active ingredients: Risankizumab

Original BDPM details in French

Official name: SKYRIZI 75 mg, solution injectable en seringue préremplie
Active ingredients: RISANKIZUMAB
Package description: 2 seringues préremplies en verre de 0,83 ml (75 mg/0,83 ml) + 2 compresses d’alcool

CIS 67060271CIP7 3017488CIP13 3400930174883

View details

Estimated price€5,487.52No current ANSM shortage notice is included

Commercialized according to BDPM

ULTOMIRIS 1100 mg/11 ml, concentrate for solution for infusion

Active ingredients: Ravulizumab

Original BDPM details in French

Official name: ULTOMIRIS 1100 mg/11 mL, solution à diluer pour perfusion
Active ingredients: RAVULIZUMAB
Package description: 1 flacon(s) en verre de 11 ml

CIS 64265627CIP7 5508237CIP13 3400955082378

View details

Estimated priceAsk the manager for the priceNo current ANSM shortage notice is included

Commercialized according to BDPM

ULTOMIRIS 300 mg/3 ml, concentrate for solution for infusion

Active ingredients: Ravulizumab

Original BDPM details in French

Official name: ULTOMIRIS 300 mg/3 mL, solution à diluer pour perfusion
Active ingredients: RAVULIZUMAB
Package description: 1 flacon(s) en verre de 3 ml

CIS 61808523CIP7 5508238CIP13 3400955082385

View details

Estimated priceAsk the manager for the priceNo current ANSM shortage notice is included

The displayed price is an estimate. It is not an offer to sell or confirmation of stock. Current catalog version published 4 Nov 2026.